The above data support the presence of FAP in different forms of atherosclerosis and the role of FAP as a potential target, not only in native atherosclerosis, but also in vein graft atherosclerosis and post-transplant arteriosclerosis, which currently have very limited therapeutic options available. Here, FAP is linked to arteriosclerosis disorder.